300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Oil and Gas
Mobile
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Social Media
FinTech
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Colombia
Guernsey
Cameroon
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Paraguay
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Huajin Capital, VC Fund

Huajin Capital

VC Fund

Zhuhai, China

Huajin Capital is a VC fund in Zhuhai focused on Biotechnology and Biopharma. Huajin Capital engages in equity investment, asset management, physical, and incubator.

Total investments:
46
Last investment:
Lead investor:
28%

Last updated:

Industries Huajin Capital invests in

BiotechnologyBiopharmaManufacturingMedicalHealth Care

Stages Huajin Capital invests in

Series ASeedSeries BSeries CSeries D

Countries Huajin Capital invests in

ChinaUnited States

Contacts

NameEmailPhoneSocials
Liu Feihong

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 9 (20%)
  • Biopharma 7 (15%)
  • Manufacturing 7 (15%)
  • Medical 6 (13%)
  • Health Care 5 (11%)
See all 38 industries →

Stage

  • Series A 10 (22%)
  • Seed 6 (13%)
  • Series B 6 (13%)
  • Series C 5 (11%)
  • Series D 4 (9%)
See all 10 stages →

Country

  • China 29 (63%)
  • United States 4 (9%)

Team

NameTitleInvestmentsLinksEmail
Liu Feihong Managing Director
Managing Director Total investments: 3 Find email

Investments

CompanyDescriptionRoundLinks
Dongsheng Fusion
Dongsheng Fusion is a magnetic confinement fusion technology company that develops miniaturized fusion power plant technology. $100M / Seed / Jun 08, 2026
Zhide New Energy Zhide New Energy
Zhide New Energy is a developer of high-capacity silicon anode materials for lithium batteries $87.8M / Series E / Apr 09, 2026
Zenitar Zenitar
Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia. $86M / Series C / Jan 12, 2026
GigaAI GigaAI
Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space. $28.3M / Series A / Dec 08, 2025
HAAWKING HAAWKING
Haawking is a supplier of digital signal processors. Their products used in industrial control, motor drives, digital power supplies, photo voltaic, energy storage, new energy automotive and consumer electronics. Their customer can contact through mail id and phone number. Series B / Jun 17, 2025
HighlightLL Pharma HighlightLL Pharma
HighlightLL Pharma is a pharmaceutical company. $20.5M / Series C / Jan 03, 2025
SENASIC SENASIC
SENASIC focuses on the development, design and sales of high-performance chips and sensors related to automotive and industrial IoT applications. SENASIC's main products include the automotive tire pressure sensor series, the MAP sensor series and the industrial-grade wireless temperature sensor series for the Internet of Things. SENASIC hasmany years of technical accumulation and autonomous IP in low-power MCU, high-precision ADC, low-frequency 125kHz interface, acceleration detection interface, RF transmission and other core functional modules. SENASIC has accumulated a lot of experience in chip packaging, testing, calibration and reliability technology to ensure the automotive quality of sensor products. The company's automotive tire pressure sensor has reached AEC-Q10 Series D / Nov 26, 2024
Huali Juneng Huali Juneng
Huali Juneng is a pressure vessel and related equipment producer specializing in petroleum, chemical, oil, electricity, desalination, and medical. $110.6M / Seed / Nov 18, 2024
Bivision Bivision
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment. $13.8M / Series A / Jul 26, 2024
Mellow Energy Mellow Energy
Mellow Energy Technology is a new calcium ore photovoltaic cell enterprise. Its business is the research and development, production and sales of centralized and distributed photovoltaic power stations. Seed / May 09, 2024
See all 46 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Oil and Gas
Mobile
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Social Media
FinTech
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Colombia
Guernsey
Cameroon
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Paraguay
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Huajin Capital invest in?

Huajin Capital invests primarily in Biotechnology, Biopharma and Manufacturing startups, most often at Series A and Seed stage. Most of the 46 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Huajin Capital?

Public channels for Huajin Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Huajin Capital?

The team at Huajin Capital includes Liu Feihong (Managing Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Huajin Capital Huajin Capital Find emails